Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Melanoma Stage III · Melanoma Stage IV · BRAF V600 Mutation
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Moffitt Cancer Center, Tampa, Florida, United States
Contact: Principal Investigator (Zeynep Eroglu, MD)Andrew Brohl, MD (Sub-investigator)Nikhil Khushaslani, MD (Sub-investigator)Joseph Markowitz, MD, PhD (Sub-investigator)Ahmad Tarhini, MD, PhD (Sub-investigator)
Study leads
Zeynep Eroglu, MD
Principal Investigator
Moffitt Cancer Center